Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial

• Joakim Dillner,
• Camilla Lagheden,
• Eero Pukkala,
• Tiina Eriksson,
• Tapio Luostarinen,
• Dan Apter,
• Matti Lehtinen,
• Katja Harjula,
• Marjo Kuortti,
• Johanna Palmroth,
• Tiina Petäjä,
• Pekka Nieminen,
• J Paavonen,
• Anne Bly,
• Penelope Gray,
• Kaisa Heikkilä,
• Mari Hokkanen,
• Heidi Karttunen,
• Mervi Nummela,
• Anna Soderlund-Strand,
• Ulla Veivo

Affiliations

Joakim Dillner

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Camilla Lagheden

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

Eero Pukkala

Cancer Society of Finland, Helsinki, Finland

Tiina Eriksson

FICAN-Mid, Tampere, Finland

Tapio Luostarinen

Finnish Cancer Registry, Helsinki, Finland

Dan Apter

VL Medi, Helsinki, Finland

Matti Lehtinen

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

Katja Harjula

Tampere University Hospital, Tampere, Finland

Marjo Kuortti

Faculty of Social Sciences, Tampereen Yliopisto, Tampere, Finland

Johanna Palmroth

University of Eastern Finland School of Medicine, Kuopio, Pohjois-Savo, Finland

Tiina Petäjä

Obstetrics & Gynecology, Tampereen Yliopisto, Seinäjoki, Finland

Pekka Nieminen

Helsingin Yliopisto, Helsinki, Finland

J Paavonen

Department of Gynecology and Obstetrics, University of Helsinki, Helsinki, Finland

Anne Bly

Tampere University Hospital, Tampere, Finland

Penelope Gray

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

Kaisa Heikkilä

Tampere University Hospital, Tampere, Finland

Mari Hokkanen

Tampere University Hospital, Tampere, Finland

Heidi Karttunen

Tampere University Hospital, Tampere, Finland

Mervi Nummela

Tampere University Hospital, Tampere, Finland

Anna Soderlund-Strand

Clinical Microbiology, Lund University, Lund, Sweden

Ulla Veivo

Tampere University Hospital, Tampere, Finland